Anti-SARS-CoV-2 cellular response after 2 and 3 doses of BNT162b2 mRNA vaccine in lymphoma patients receiving anti-CD20 antibodies

被引：4
|
作者：
Gressens, Simon B. [1 ]
Wiedemann, Aurelie [2 ,4 ]
Dechenaud, Marie [2 ]
Dupuis, Jehan [3 ]
Gallien, Sebastien [1 ,4 ]
Melica, Giovanna [1 ,4 ]
Haioun, Corinne [3 ,4 ]
Lemonnier, Francois [3 ,4 ]
Levy, Yves [1 ,2 ]
机构：
[1] Univ Paris Est Creteil, Hop Univ Henri Mondor, AP HP, Infect Dis & Immunol Dept, Creteil, France
[2] Univ Paris Est Creteil, Vaccine Res Inst, Fac Med, Team 16,INSERM U955, Creteil, France
[3] Grp Hosp Univ Chenevier Mondor, Serv Unite Hemopathies Lymphoides, IAP HP, F-94010 Creteil, France
[4] Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France
来源：
VACCINE | 2023年 / 41卷 / 09期
关键词：
Third dose; COVID-19; Immunocompromised; Vaccine; T cell responses; Hematological malignancies; SARS-COV-2; IMMUNITY;
D O I：
10.1016/j.vaccine.2023.01.064
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Patients receiving anti-CD20 antibodies showed limited efficacy of a booster dose of BNT162b2. Patients with lymphomas combine such immunotherapies with cytotoxic chemotherapies that could result in an even greater alteration of the immune response to vaccination. We report here the impact of a third vac-cine dose on T cell specific responses in a small cohort of patients treated in our center by anti-CD20 ther-apies and cytotoxic chemotherapies for lymphoid malignancies. Our results showed that a third dose in these severely immune suppressed patients could improve the expansion on CD4+Th1+T cell responses while the effect CD8 + T cell responses was marginal. (c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1550 / 1553
页数：4
相关论文
共 50 条
  • [41] Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases
    Udaondo, Clara
    Camara, Carmen
    Berenguel, Laura Miguel
    Rueda, Rosa Alcobendas
    Gomez, Celia Munoz
    Longo, Claudia Millan
    Diaz-Delgado, Blanca
    Falces-Romero, Iker
    Almiron, Mariana Diaz
    Ochando, Jordi
    Mendez-Echevarria, Ana
    Camba, Agustin Remesal
    Calvo, Cristina
    PEDIATRIC RHEUMATOLOGY, 2022, 20 (01)
  • [42] Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
    Pellicano, Chiara
    Campagna, Roberta
    Oliva, Alessandra
    Leodori, Giorgia
    Miglionico, Marzia
    Colalillo, Amalia
    Mezzaroma, Ivano
    Mastroianni, Claudio Maria
    Turriziani, Ombretta
    Rosato, Edoardo
    CLINICAL RHEUMATOLOGY, 2022, 41 (09) : 2755 - 2763
  • [43] Evaluation of Immunogenicity to Three Doses of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Lung Transplant Patients
    Guardiani, Mariasilvia
    Zingaropoli, Maria Antonella
    Dezza, Francesco Cogliati
    Centofanti, Anastasia
    Carillo, Carolina
    Tortellini, Eeva
    Dominelli, Federica
    Napoli, Anna
    Del Borgo, Cosmo
    Gaeta, Aurelia
    Venuta, Federico
    Vullo, Vincenzo
    Lichtner, Miriam
    Ciardi, Maria Rosa
    Mastroianni, Claudio Maria
    Russo, Gianluca
    VACCINES, 2022, 10 (10)
  • [44] A Case of Acute Interstitial Nephritis After Two Doses of the BNT162b2 SARS-CoV-2 Vaccine
    Mira, Filipe S.
    Carvalho, Joni Costa
    de Almeida, Patricia Amaral
    Pimenta, Ana Carolina
    Coutinho, Iolanda Alen
    Figueiredo, Carolina
    Rodrigues, Luis
    Sousa, Vitor
    Ferreira, Emanuel
    Pinto, Helena
    Escada, Luis
    Galvao, Ana
    Alves, Rui
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2021, 14 : 421 - 426
  • [45] Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection
    Psichogiou, Mina
    Karabinis, Andreas
    Poulakou, Garyphallia
    Antoniadou, Anastasia
    Kotanidou, Anastasia
    Degiannis, Dimitrios
    Pavlopoulou, Ioanna D.
    Chaidaroglou, Antigoni
    Roussos, Sotirios
    Mastrogianni, Elpida
    Eliadi, Irene
    Basoulis, Dimitrios
    Petsios, Konstantinos
    Leontis, Konstantinos
    Kakalou, Eleni
    Protopapas, Konstantinos
    Jahaj, Edison
    Pratikaki, Maria
    Syrigos, Konstantinos N.
    Lagiou, Pagona
    Gogas, Helen
    Tsiodras, Sotirios
    Magiorkinis, Gkikas
    Paraskevis, Dimitrios
    Sypsa, Vana
    Hatzakis, Angelos
    VACCINES, 2021, 9 (09)
  • [46] SARS-CoV-2 Antibody Response to the BNT162b2 mRNA Vaccine in Persons with Past Natural Infection
    Kang, Yu Min
    Choe, Kang-Won
    Lee, Ki-Deok
    Kim, Kwang Nam
    Kim, Moon Jung
    Lim, Jaegyun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (35)
  • [47] Waning Humoral Response 3 to 6 Months after Vaccination with the SARS-COV-2 BNT162b2 mRNA Vaccine in Dialysis Patients
    Berar-Yanay, Noa
    Freiman, Sarit
    Shapira, MaMODIFIER L. E. T. T. E. R. PRIMEanit
    Saffoury, Amer
    Elemy, Ameer
    Hamze, Munir
    Elhaj, Mohamad
    Zaher, Maha
    Matanis, Loai
    Armaly, Zaher Anis
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [48] Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2
    Xia, Hongjie
    Zou, Jing
    Kurhade, Chaitanya
    Cai, Hui
    Yang, Qi
    Cutler, Mark
    Cooper, David
    Muik, Alexander
    Jansen, Kathrin U.
    Xie, Xuping
    Swanson, Kena A.
    Shi, Pei-Yong
    CELL HOST & MICROBE, 2022, 30 (04) : 485 - +
  • [49] Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)
    Favresse, Julien
    Bayart, Jean-Louis
    Mullier, Francois
    Dogne, Jean-Michel
    Closset, Melanie
    Douxfils, Jonathan
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (09) : 1351.e5 - 1351.e7
  • [50] Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort
    Mauro, Daniele
    Ciancio, Antonio
    Di Vico, Claudio
    Passariello, Luana
    Rozza, Gelsomina
    Pasquale, Maria Dora
    Pantano, Ilenia
    Cannistra, Carlo
    Bucci, Laura
    Scriffignano, Silvia
    Riccio, Flavia
    Patrone, Martina
    Scalise, Giuseppe
    Ruscitti, Piero
    Montemurro, Maria Vittoria
    Giordano, Antonio
    Vietri, Maria Teresa
    Ciccia, Francesco
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345